BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30006662)

  • 1. Current state of the art in continuous bioprocessing.
    Schofield M
    Biotechnol Lett; 2018 Oct; 40(9-10):1303-1309. PubMed ID: 30006662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitation as an Enabling Technology for the Intensification of Biopharmaceutical Manufacture.
    Martinez M; Spitali M; Norrant EL; Bracewell DG
    Trends Biotechnol; 2019 Mar; 37(3):237-241. PubMed ID: 30316558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing.
    Esmonde-White KA; Cuellar M; Uerpmann C; Lenain B; Lewis IR
    Anal Bioanal Chem; 2017 Jan; 409(3):637-649. PubMed ID: 27491299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous downstream processing of biopharmaceuticals.
    Jungbauer A
    Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
    Cole KP; Johnson MD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK.
    Farid SS; Thompson B; Davidson A
    MAbs; 2014; 6(6):1357-61. PubMed ID: 25484060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved virus purification processes for vaccines and gene therapy.
    Nestola P; Peixoto C; Silva RR; Alves PM; Mota JP; Carrondo MJ
    Biotechnol Bioeng; 2015 May; 112(5):843-57. PubMed ID: 25677990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous processing for production of biopharmaceuticals.
    Rathore AS; Agarwal H; Sharma AK; Pathak M; Muthukumar S
    Prep Biochem Biotechnol; 2015; 45(8):836-49. PubMed ID: 25674930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of industrial bioprocessing: batch or continuous?
    Croughan MS; Konstantinov KB; Cooney C
    Biotechnol Bioeng; 2015 Apr; 112(4):648-51. PubMed ID: 25694022
    [No Abstract]   [Full Text] [Related]  

  • 13. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous downstream processing for high value biological products: A Review.
    Zydney AL
    Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges and recent advances on the path towards continuous biomanufacturing.
    Drobnjakovic M; Hart R; Kulvatunyou BS; Ivezic N; Srinivasan V
    Biotechnol Prog; 2023; 39(6):e3378. PubMed ID: 37493037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile and on-demand biologics co-production in yeast.
    Cao J; Perez-Pinera P; Lowenhaupt K; Wu MR; Purcell O; de la Fuente-Nunez C; Lu TK
    Nat Commun; 2018 Jan; 9(1):77. PubMed ID: 29311542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of capillary electrophoresis in the analysis of molecules with pharmaceutical and biotechnological value].
    Taverna M; Baillet A; Baylocq-Ferrier D; Pellerin F
    Ann Pharm Fr; 1992; 50(4):199-214. PubMed ID: 1306615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.